UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (871) 871
life sciences & biomedicine (846) 846
animals (698) 698
humans (692) 692
biochemistry & molecular biology (339) 339
disintegrins - metabolism (307) 307
mice (279) 279
amino acid sequence (251) 251
molecular sequence data (238) 238
metalloendopeptidases - metabolism (236) 236
adam proteins (230) 230
male (206) 206
membrane proteins - metabolism (202) 202
female (199) 199
adam proteins - metabolism (195) 195
cell biology (189) 189
disintegrin (189) 189
disintegrins - genetics (189) 189
biological and medical sciences (183) 183
metalloendopeptidases - genetics (174) 174
disintegrins - chemistry (154) 154
adam proteins - genetics (137) 137
membrane proteins - genetics (134) 134
medical sciences (130) 130
disintegrins - pharmacology (125) 125
cell line, tumor (119) 119
disintegrins (113) 113
cells, cultured (112) 112
proteins (111) 111
oncology (103) 103
signal transduction (103) 103
cell line (98) 98
protein structure, tertiary (96) 96
metalloendopeptidases - chemistry (88) 88
gene expression (87) 87
protein binding (85) 85
base sequence (84) 84
sequence homology, amino acid (84) 84
adam17 protein (83) 83
biophysics (82) 82
cloning, molecular (81) 81
pharmacology & pharmacy (81) 81
metalloproteinase (79) 79
rats (78) 78
analysis (77) 77
fundamental and applied biological sciences. psychology (76) 76
venom (72) 72
integrins (71) 71
cell adhesion - drug effects (70) 70
integrins - metabolism (70) 70
toxicology (67) 67
adam10 protein (66) 66
proteases (65) 65
transfection (64) 64
cell adhesion (63) 63
middle aged (63) 63
adult (62) 62
platelet aggregation - drug effects (61) 61
adam (60) 60
adamts1 protein (60) 60
binding sites (59) 59
rna, messenger - metabolism (59) 59
metalloprotease (58) 58
crotalid venoms - chemistry (56) 56
enzymes (56) 56
reverse transcriptase polymerase chain reaction (56) 56
immunohistochemistry (54) 54
neurosciences & neurology (54) 54
aged (53) 53
dose-response relationship, drug (53) 53
platelet aggregation inhibitors - pharmacology (53) 53
amyloid precursor protein secretases - metabolism (52) 52
blotting, western (52) 52
integrin (52) 52
neurosciences (52) 52
sequence alignment (52) 52
tumor cells, cultured (52) 52
mice, inbred c57bl (51) 51
metalloproteases - metabolism (50) 50
recombinant proteins - metabolism (49) 49
research article (49) 49
apoptosis (48) 48
research (48) 48
adam12 protein (47) 47
cell proliferation (47) 47
peptides - pharmacology (47) 47
physiological aspects (47) 47
abridged index medicus (45) 45
amyloid precursor protein secretases (45) 45
ligands (45) 45
extracellular matrix (44) 44
metastasis (44) 44
mutation (44) 44
angiogenesis (43) 43
cell membrane - metabolism (43) 43
collagen (43) 43
crotalid venoms - pharmacology (43) 43
extracellular matrix - metabolism (42) 42
proteolysis (42) 42
tumors (42) 42
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of cell biology, ISSN 0021-9525, 3/2004, Volume 164, Issue 5, pp. 769 - 779
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 02/2018, Volume 218, Issue 2, pp. S725 - S737
fetal biometry | models | screening | small for gestational age | human placental lactogen | stillbirth | alpha fetoprotein | biomarker | placental protein 13 | pregnancy-associated plasma protein-A | study design | fetal death | ultrasound | inhibin | randomized controlled trial | placental growth factor | human chorionic gonadotropin | review | prediction | placenta | soluble fms-like tyrosine kinase-1 | A-disintegrin and metalloprotease 12 | soluble endoglin | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Fetal Growth Retardation - diagnostic imaging | ADAM12 Protein - metabolism | Humans | Placenta Growth Factor - metabolism | Pregnancy Proteins - metabolism | Placental Lactogen - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Estriol - metabolism | Placental Circulation | Female | Membrane Proteins - metabolism | Fetal Growth Retardation - diagnosis | alpha-Fetoproteins - metabolism | Biomarkers - metabolism | Prenatal Diagnosis | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Fetal Growth Retardation - metabolism | Laser-Doppler Flowmetry | Biometry | Chorionic Gonadotropin - metabolism | Pregnancy | Inhibins - metabolism | Ultrasonography, Prenatal | Endoglin - metabolism | Pregnancy-Associated Plasma Protein-A - metabolism | Galectins - metabolism | Tyrosine | Medical research | Chorionic gonadotropin | Medical examination | Growth | Inhibin | Medical screening | Obstetrics | Blood | Somatotropin | Pregnant women | Analysis | Medicine, Experimental | Fetus | Biological markers | Health aspects | Blood proteins | Index Medicus | Abridged Index Medicus
Journal Article
Molecular carcinogenesis, ISSN 0899-1987, 01/2017, Volume 56, Issue 1, pp. 18 - 35
cellular effectors | disintegrin | tumor growth | Lebein | colon cancer | Biochemistry & Molecular Biology | Oncology | Life Sciences & Biomedicine | Science & Technology | Colonic Neoplasms - genetics | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Colonic Neoplasms - drug therapy | Humans | Colon - drug effects | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Colonic Neoplasms - metabolism | Neovascularization, Pathologic - pathology | Antineoplastic Agents - pharmacology | Colon - pathology | Models, Molecular | Viper Venoms - pharmacology | Down-Regulation - drug effects | Colon - metabolism | Integrin beta1 - metabolism | Animals | MAP Kinase Signaling System - drug effects | Cell Cycle Checkpoints - drug effects | Mice, Nude | Neovascularization, Pathologic - drug therapy | Chickens | Colonic Neoplasms - pathology | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Neovascularization, Pathologic - metabolism | Viper Venoms - therapeutic use | Fibronectins | Development and progression | Colon cancer | Venom | Cell cycle | Cancer cells | Mice | Neovascularization | Tumor proteins | Vascular endothelial growth factor | Tumors | Integrins | Apoptosis | Angiogenesis | Cancer therapies | Colorectal cancer | Index Medicus | Vascular Endothelial Growth Factor A/genetics | Neovascularization, Pathologic/drug therapy | Neovascularization, Pathologic/pathology | Antineoplastic Agents/therapeutic use | Colon/pathology | Life Sciences | Antineoplastic Agents/pharmacology | Colonic Neoplasms/metabolism | Colon/drug effects | Cell Proliferation/drug effects | Reactive Oxygen Species/metabolism | Down-Regulation/drug effects | Colonic Neoplasms/genetics | Integrin beta1/metabolism | Biochemistry, Molecular Biology | Apoptosis/drug effects | Vascular Endothelial Growth Factor A/metabolism | Colon/metabolism | MAP Kinase Signaling System/drug effects | Human health and pathology | Neovascularization, Pathologic/metabolism | Viper Venoms/pharmacology | Cell Cycle Checkpoints/drug effects | Colonic Neoplasms/pathology | Viper Venoms/therapeutic use | Colonic Neoplasms/drug therapy | Neovascularization, Pathologic/genetics | Cancer
Journal Article
Genetics (Austin), ISSN 0016-6731, 06/2019, Volume 212, Issue 2, pp. 523 - 535
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Metalloendopeptidases - genetics | Caenorhabditis elegans Proteins - metabolism | Extracellular Matrix - metabolism | Metalloendopeptidases - metabolism | Disintegrins - genetics | Tissue Inhibitor of Metalloproteinases - genetics | Intercellular Signaling Peptides and Proteins - metabolism | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Gonads - growth & development | Cell Membrane - metabolism | Germ Cells - metabolism | Collagen Type IV - metabolism | Tissue Inhibitor of Metalloproteinase-1 - physiology | Caenorhabditis elegans - metabolism | Caenorhabditis elegans - growth & development | Disintegrins - metabolism | Morphogenesis - genetics | Caenorhabditis elegans - genetics | Intercellular Signaling Peptides and Proteins - genetics | Basement Membrane - metabolism | Tissue Inhibitor of Metalloproteinases - metabolism | Tissue Inhibitor of Metalloproteinase-1 - genetics | Gonads - metabolism | Animals | Caenorhabditis elegans Proteins - genetics | Morphogenesis - physiology | Germ cells | Transcription | Genes | Remodeling | Tissues | Tissue inhibitor of metalloproteinase 1 | Defects | Deletion mutant | Cell adhesion & migration | Morphogenesis | Clonal deletion | Proteolysis | Extracellular matrix | Collagen (type IV) | Localization | Worms | Thrombospondin | Phenotypes | ADAM protein | Mammals | Sterility | Zinc | Mutants | Inhibitors | Insects | Morphology | Collagen | Regulatory mechanisms (biology) | Nematodes | Mutation | Gonads | Index Medicus | type IV collagen | a disintegrin and metalloproteinase with thrombospondin motifs | tissue inhibitors of metalloproteinases | gonad | Investigations | extracellular matrix
Journal Article
Drug resistance updates, ISSN 1368-7646, 2005, Volume 8, Issue 6, pp. 381 - 402
Therapeutic proteins | Angiogenesis | Gene delivery | Arg-Gly-Asp | Drug delivery | Antivascular therapies | Polymers | Radiotracer | RGD | Endothelial cells | Cytostatic drugs | Cancer | endothelial cells | VITRONECTIN RECEPTOR ANTAGONIST | SNAKE-VENOM DISINTEGRINS | angiogenesis | NECROSIS-FACTOR-ALPHA | drug delivery | UMCG Approved | therapeutic proteins | CANCER ALPHA(V)-INTEGRIN EXPRESSION | gene delivery | POTENT ANTITUMOR-ACTIVITY | CONDITIONALLY REPLICATIVE ADENOVIRUSES | POSITRON-EMISSION-TOMOGRAPHY | radiotracer | cytostatic drugs | ALPHA(V)BETA INTEGRIN ANTAGONISTS | VIRUS-LIKE PARTICLES | cancer | antivascular therapies | polymers | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Neoplasms - metabolism | Recombinant Proteins - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Doxorubicin - therapeutic use | Genetic Therapy | RNA, Small Interfering - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Drug Carriers - chemistry | Integrin alphaVbeta3 - metabolism | Peptides, Cyclic - metabolism | Oligopeptides - therapeutic use | Antineoplastic Agents - metabolism | Transfection | Neoplasms - genetics | Doxorubicin - analogs & derivatives | Doxorubicin - metabolism | Oligopeptides - chemistry | Polyethylene Glycols - metabolism | Recombinant Proteins - metabolism | Endothelial Cells - metabolism | Oligopeptides - genetics | Genetic Vectors - metabolism | Clinical Trials as Topic | Oligopeptides - metabolism | Genetic Vectors - genetics | Neoplasms - drug therapy | Integrin alphaVbeta3 - analysis | Tumor Necrosis Factor-alpha - therapeutic use | Animals | Mutation | RNA, Small Interfering - metabolism | Proteins | Drugs | Drug delivery systems | Care and treatment | Peptides | Radioactive tracers | Health aspects | Tumors | Vehicles | Index Medicus
Journal Article